Based on their distinctive molecular profiling, breast cancers can be grouped in different subtypes: estrogen-receptor positive luminal, ERBB2+ (or HER2+), basal-like (also referred as triple negative due to absence of ER, PR and HER2) and claudin-low [3,4,5,6]. Here, ERBB2 is linked to breast carcinoma.